Synteract cites global expansion as driver for HCR takeover

- Last updated on GMT

Related tags: Clinical trial, Europe

Synteract to buy HCR to expand reach
Synteract to buy HCR to expand reach
Synteract will add trial capacity in Europe, Israel and South America through the acquisition of Munich-based Harrison Clinical Research. (HCR).

The proposed acquisition – financial terms of which were not disclosed by the private equity-owned, San Francisco-headquartered contract research organisation (CRO) – will add HCR’s capabilities in early phase pharmacology and Phase II to IV services.

The deal – which is expected to complete in the first quarter – will create a combined company with a workforce of 800 employees in 16 countries under the leadership of Synteract CEO Wendel Barr.

Francisco Harrison – HCR founder and current chairman – will take a seat on the Synteract board and the Germany firm’s CEO Benedikt van Nieuwenhove will take change of operations in Europe.

Alex Earls, a spokesman for Synteract’s private-equity owners Gryphon Investors, explained that global expansion is the key motivated for the takeover.

The acquisition provides Synteract with a strong geographic presence in Western and Eastern Europe and an emerging presence in South America.

Importantly, this acquisition will allow Synteract to more effectively meet the global trial needs of its customer base and brings significant adaptive trial, medical device and nutraceutical expertise to the combined company.”

Synteract’s only current European operation is its office in Prague in the Czech Republic that it opened in 2009​ in a bid to increase its access to treatment naïve clinical trial participants.

Related news

Show more

Related products

show more

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars